454 related articles for article (PubMed ID: 9776276)
1. Significance of nonuniform attenuation correction in quantitative brain SPECT imaging.
Rajeevan N; Zubal IG; Ramsby SQ; Zoghbi SS; Seibyl J; Innis RB
J Nucl Med; 1998 Oct; 39(10):1719-26. PubMed ID: 9776276
[TBL] [Abstract][Full Text] [Related]
2. Contribution of scatter and attenuation compensation to SPECT images of nonuniformly distributed brain activities.
Kim KM; Varrone A; Watabe H; Shidahara M; Fujita M; Innis RB; Iida H
J Nucl Med; 2003 Apr; 44(4):512-9. PubMed ID: 12679393
[TBL] [Abstract][Full Text] [Related]
3. Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-beta-CIT SPECT data.
Ichise M; Kim YJ; Erami SS; Ballinger JR; Vines D; Tanaka F; Lang AE
J Nucl Med; 1999 Apr; 40(4):530-8. PubMed ID: 10210210
[TBL] [Abstract][Full Text] [Related]
4. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
[TBL] [Abstract][Full Text] [Related]
5. Nonuniform transmission in brain SPECT using 201Tl, 153Gd, and 99mTc static line sources: anthropomorphic dosimetry studies and influence on brain quantification.
Van Laere K; Koole M; Kauppinen T; Monsieurs M; Bouwens L; Dierck R
J Nucl Med; 2000 Dec; 41(12):2051-62. PubMed ID: 11138692
[TBL] [Abstract][Full Text] [Related]
6. Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.
Seibyl JP; Marek K; Sheff K; Baldwin RM; Zoghbi S; Zea-Ponce Y; Charney DS; van Dyck CH; Hoffer PB; Innis RB
J Nucl Med; 1997 Sep; 38(9):1453-9. PubMed ID: 9293807
[TBL] [Abstract][Full Text] [Related]
7. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
[TBL] [Abstract][Full Text] [Related]
8. Automated stereotactic standardization of brain SPECT receptor data using single-photon transmission images.
Van Laere K; Koole M; D'Asseler Y; Versijpt J; Audenaert K; Dumont F; Dierckx R
J Nucl Med; 2001 Feb; 42(2):361-75. PubMed ID: 11216537
[TBL] [Abstract][Full Text] [Related]
9. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
[TBL] [Abstract][Full Text] [Related]
10. SPECT-evaluation of the monoamine uptake site ligand [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I]beta-CIT) in untreated patients with suspicion of Parkinson disease.
Eising EG; Müller TT; Zander C; Kuhn W; Farahati J; Reiners C; Coenen HH
J Investig Med; 1997 Oct; 45(8):448-52. PubMed ID: 9394097
[TBL] [Abstract][Full Text] [Related]
11. Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT.
Kim SE; Choi JY; Choe YS; Choi Y; Lee WY
J Nucl Med; 2003 Jun; 44(6):870-6. PubMed ID: 12791812
[TBL] [Abstract][Full Text] [Related]
12. Effects of scatter and attenuation correction on quantitative assessment of regional cerebral blood flow with SPECT.
Iida H; Narita Y; Kado H; Kashikura A; Sugawara S; Shoji Y; Kinoshita T; Ogawa T; Eberl S
J Nucl Med; 1998 Jan; 39(1):181-9. PubMed ID: 9443759
[TBL] [Abstract][Full Text] [Related]
13. Extracardiac activity complicates quantitative cardiac SPECT imaging using a simultaneous transmission-emission approach.
Heller EN; DeMan P; Liu YH; Dione DP; Zubal IG; Wackers FJ; Sinusas AJ
J Nucl Med; 1997 Dec; 38(12):1882-90. PubMed ID: 9430462
[TBL] [Abstract][Full Text] [Related]
14. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.
Seibyl JP; Laruelle M; van Dyck CH; Wallace E; Baldwin RM; Zoghbi S; Zea-Ponce Y; Neumeyer JL; Charney DS; Hoffer PB; Innis RB
J Nucl Med; 1996 Feb; 37(2):222-8. PubMed ID: 8667048
[TBL] [Abstract][Full Text] [Related]
15. Attenuation compensation in 99mTc SPECT brain imaging: a comparison of the use of attenuation maps derived from transmission versus emission data in normal scans.
Licho R; Glick SJ; Xia W; Pan TS; Penney BC; King MA
J Nucl Med; 1999 Mar; 40(3):456-63. PubMed ID: 10086711
[TBL] [Abstract][Full Text] [Related]
16. Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease.
Asenbaum S; Brücke T; Pirker W; Podreka I; Angelberger P; Wenger S; Wöber C; Müller C; Deecke L
J Nucl Med; 1997 Jan; 38(1):1-6. PubMed ID: 8998140
[TBL] [Abstract][Full Text] [Related]
17. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters.
Booij J; Busemann Sokole E; Stabin MG; Janssen AG; de Bruin K; van Royen EA
Eur J Nucl Med; 1998 Jan; 25(1):24-30. PubMed ID: 9396871
[TBL] [Abstract][Full Text] [Related]
18. [Development of a Striatal and Skull Phantom for Quantitative
Ishiguro M; Uno M; Miyazaki T; Kataoka Y; Toyama H; Ichihara T
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2018; 74(2):124-132. PubMed ID: 29459538
[TBL] [Abstract][Full Text] [Related]
19. Imaging and quantitation of dopamine transporters with iodine-123-IPT in normal and Parkinson's disease subjects.
Kim HJ; Im JH; Yang SO; Moon DH; Ryu JS; Bong JK; Nam KP; Cheon JH; Lee MC; Lee HK
J Nucl Med; 1997 Nov; 38(11):1703-11. PubMed ID: 9374337
[TBL] [Abstract][Full Text] [Related]
20. [123I]beta-CIT SPECT visualizes dopamine transporter loss in de novo parkinsonian patients.
Müller T; Farahati J; Kuhn W; Eising EG; Przuntek H; Reiners C; Coenen HH
Eur Neurol; 1998; 39(1):44-8. PubMed ID: 9476723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
